Nine drugmakers have been fined by EU competition regulators for blocking a cheaper anti-depressant medicine from coming to the market.
Danish firm Lundbeck was hit with the largest fine - almost 94 million euros.
The eight others - the biggest of which was Germany's Merck - were fined a combined 52 million.
...
http://www.euronews.net/